Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by K. J. Hare
The Intestinotrophic Peptide, GLP-2, Counteracts Intestinal Atrophy in Mice Induced by the Epidermal Growth Factor Receptor Inhibitor, Gefitinib
Clinical Cancer Research
Cancer Research
Oncology
Related publications
Gefitinib-Induced Cardiomyopathy in Epidermal Growth Receptor-Mutated NSCLC
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Nursing Management of Epidermal Growth Factor Receptor Inhibitor-Induced Toxicities
Clinical Journal of Oncology Nursing
Oncology
Symmetrical Drug-Related Intertriginous and Flexural Exanthema Secondary to Epidermal Growth Factor Receptor Inhibitor Gefitinib
JAAD Case Reports
Dermatology
Epidermal Growth Factor Receptor Transactivation Is Required for Proteinase-Activated Receptor-2-Induced COX-2 Expression in Intestinal Epithelial Cells
American Journal of Physiology - Gastrointestinal and Liver Physiology
Hepatology
Physiology
Gastroenterology
Autophagic Degradation of Epidermal Growth Factor Receptor in Gefitinib-Resistant Lung Cancer by Celastrol
International Journal of Oncology
Cancer Research
Oncology
Epidermal Growth Factor Receptor (EGFR) Is Overexpressed in Anaplastic Thyroid Cancer, and the EGFR Inhibitor Gefitinib Inhibits the Growth of Anaplastic Thyroid Cancer
Clinical Cancer Research
Cancer Research
Oncology
Glucagon-Like Peptide 2 (GLP-2) Accelerates the Growth of Colonic Neoplasms in Mice
Gut
Gastroenterology
Chemopreventive Effects of Gefitinib on Nonsmoking-Related Lung Tumorigenesis in Activating Epidermal Growth Factor Receptor Transgenic Mice
Cancer Research
Cancer Research
Oncology
COX-2/sEH Dual Inhibitor PTUPB Suppresses Glioblastoma Growth by Targeting Epidermal Growth Factor Receptor and Hyaluronan Mediated Motility Receptor
Oncotarget
Oncology
